Stock Events

Stock Events

MindWalk 

$1.3000
93
-$0.04-2.99% 20:00 Today
+$0.01+0.5%20:50After hours

Statistics

Day High
1.335
Day Low
1.27
52W High
2.99
52W Low
0.99
Volume
80,408
Avg. Volume
260,695
Mkt Cap
61.08M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10SepExpected
Q2 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.06
-0.06
-0.05
-0.04
Expected EPS
-0.0546559043
Actual EPS
N/A

Financials

-69.07%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
14.69MRevenue
-10.15MNet Income

Analyst Ratings

5.00Average Price Target
The highest estimate is 5.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HYFT. It's not an investment recommendation.
Satellogic
5
SATL
Microsoft
4
MSFT
NVIDIA
4
NVDA
SpaceX
4
SPCX

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals is a leading biotech company that competes in the development of monoclonal antibodies, a core area of ImmunoPrecise Antibodies' business.
Adaptive Biotechnologies
ADPT
Mkt Cap4.02B
Adaptive Biotechnologies focuses on the immune-driven discovery and development of antibodies, directly competing with IPA's antibody discovery services.
AbCellera Biologics
ABCL
Mkt Cap3.68B
AbCellera Biologics uses a technology platform for antibody discovery that rivals ImmunoPrecise Antibodies' technologies and services.
Moderna
MRNA
Mkt Cap55.09B
Moderna, known for its mRNA technology, is expanding into antibody discovery and therapeutics, positioning it as a competitor in the biotech space.
Novavax
NVAX
Mkt Cap1.53B
Novavax, primarily focused on vaccine development, competes with IPA in the broader immunotherapy and antibody development market.
BioNTech
BNTX
Mkt Cap25.64B
BioNTech SE, while known for its COVID-19 vaccine, also engages in antibody research and development, making it a competitor.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly and Company has a strong portfolio in antibody therapeutics, directly competing with IPA in the pharmaceutical and biotech market.
AMGEN
AMGN
Mkt Cap233.78B
Amgen is a biopharmaceutical company with a focus on human therapeutics, including antibodies, competing in similar therapeutic areas as IPA.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences is involved in the discovery, development, and commercialization of therapeutics, including antibodies, in areas that overlap with IPA's interests.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a global pharmaceutical company with a broad range of therapeutic products, including antibodies, competing across several of the same domains as ImmunoPrecise Antibodies.

About

MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
Show more...
CEO
Jennifer Lynne Bath
Employees
77
Country
Canada
ISIN
CA6026871054
WKN
000A41GYL

Listings

XNAS
US
HYFT
F
DE
TQB0.F
STU
DE
TQB0.STU
MU
DE
TQB0.MU

0 Comments

Share your thoughts

FAQ

What is MindWalk stock price today?▼
The current price of HYFT is $1.30 USD — it has decreased by -2.99% in the past 24 hours. Watch MindWalk stock price performance more closely on the chart.
What is MindWalk stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange MindWalk stocks are traded under the ticker HYFT.
What is MindWalk market cap?▼
Today MindWalk has the market capitalization of 61.08M
When is the next MindWalk earnings date?▼
MindWalk is going to release the next earnings report on September 10, 2026.
What were MindWalk earnings last quarter?▼
HYFT earnings for the last quarter are -0.06 USD per share, whereas the estimation was -0.04 USD resulting in a -48.01% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is MindWalk revenue for the last year?▼
MindWalk revenue for the last year amounts to 14.69M USD.
What is MindWalk net income for the last year?▼
HYFT net income for the last year is -10.15M USD.
How many employees does MindWalk have?▼
As of September 01, 2026, the company has 77 employees.
In which sector is MindWalk located?▼
MindWalk operates in the Health & Wellness sector.
When did MindWalk complete a stock split?▼
MindWalk has not had any recent stock splits.
Where is MindWalk headquartered?▼
MindWalk is headquartered in Austin, Canada.